Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed Urges “Broad-Based Approach” To AHRQ Research

This article was originally published in The Gray Sheet

Executive Summary

AHRQ's comparative clinical effectiveness research, authorized by the Medicare Modernization Act, should invoke a broader range of data than most randomized controlled trials currently offer, AdvaMed contends
Advertisement

Related Content

Private Comparative Effectiveness Arbiter Is In Industry’s Interest – Attorney
Private Comparative Effectiveness Arbiter Is In Industry’s Interest – Attorney
FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
FDA Women’s Health Director Susan Wood Resigns In Protest Over Plan B
AHRQ clinical effectiveness research
AHRQ clinical effectiveness research
Carotid Artery Disease Screening Should Make AHRQ Research List – Guidant
Carotid Artery Disease Screening Should Make AHRQ Research List – Guidant
Advertisement
UsernamePublicRestriction

Register

MT020485

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel